New BioCrossroads report highlights impressive impact of healthcare and life sciences sector in Uplands region
BLOOMINGTON, Ind. (June 16, 2022) – The Indiana Uplands region’s healthcare and life sciences sector has a $9.5 billion annual economic impact and employs more than 23,000 people in the eleven-county area1, according to a new report. The study from TEConomy Partners, ESSENTIAL: The impact of healthcare and life sciences sector in the Indiana Uplands […]
New BioCrossroads report highlights significant impact of healthcare and life sciences sector in Indiana
INDIANAPOLIS (June 15, 2022) –Indiana’s healthcare and life sciences sector has a $150 billion annual economic impact; directly employs one in every ten jobs in the state (more than 383,000 people); and has a substantial presence in the corporate and university sectors, according to a new report. The study from TEConomy Partners, ESSENTIAL: The impact […]
BioCrossroads’ new talent program recognizes the next generation of life sciences leaders 23 PAIRs (Promising Achievers in Innovation and Research) nominations are open
INDIANAPOLIS, (June 2, 2022) — People are the most valuable resource to Indiana’s life sciences sector — those who are innovating, discovering, developing and delivering critical pharmaceuticals and biotech products, medical devices, equipment, and diagnostics as well as researching and creating new protocols to accelerate getting life improving and lifesaving products to patients all over the […]
Indiana’s life sciences companies accessed more than $15 billion to grow innovation in 2021
INDIANAPOLIS (April 19, 2022) – More than $15 billion of capital was accessed by Indiana’s life sciences companies in 2021. BioCrossroads today issued their annual report, Indiana Life Sciences Capital 2021, which provides details on the funding events throughout the year, including: $6.5 million in Small Business Innovation Research (SBIR) awards to 17 companies A record […]
BioCrossroads releases 2021 annual report
In addition to global health contributions through medical innovations such as the manufacturing of three COVID-19 vaccines, Indiana’s vibrant and unique life sciences industry continues to make a significant impact on the state through its economic strength, contributing more than $79 billion in 2021. In 2021, BioCrossroads focused on collaborations among industry, academic, government and […]
Capital investments and productivity drive growth in Indiana’s life sciences industry in 2021
INDIANAPOLIS, (March 25, 2022) — Indiana’s vibrant and unique life sciences industry continues to make a significant impact on the state, contributing more than $79 billion in economic impact in 2021. A record amount of venture capital was raised by Indiana start-ups for the second straight year – increasing from $262 million in 2020 to […]
IIB: BioCrossroads Celebrates 20 Years of Growing State’s Life Sciences Sector
BioCrossroads, the life sciences initiative of the Central Indiana Corporate Partnership (CICP), is marking 20 years of growing the sector in Indiana. In that time, the life sciences sector in the state has grown to be an $80 billion industry. BioCrossroads has also invested in more than 500 startups through three venture capital funds. BioCrossroads […]
BioCrossroads celebrates two decades of advancing Indiana’s life sciences sector
INDIANAPOLIS (Feb. 14, 2022) ̶ Back in the early 2000’s no one had a doubt that Indiana was home to world-class life sciences assets, but the community was missing the opportunity to collectively advance its strengths. A coalition of organizations and business leaders decided to ensure that Central Indiana and the entire state, took advantage […]
Pharmaceutical investments lead 2021 life sciences growth in Indiana
INDIANAPOLIS (Feb. 2, 2022) ̶ In 2021, Indiana’s life sciences industry experienced strong growth in the attraction and expansion of companies across the state. Twenty-three companies committed to invest over $500 million and hire 2,100 employees. Of those 23 companies, nine committed to invest over $10 million each and two others will invest over $100 […]
BioCrossroads’ seed capital strategy connects funding with innovation
INDIANAPOLIS (Oct. 27, 2021) — For nearly 20 years, BioCrossroads has demonstrated a track record of organizing, developing and managing seed-stage and venture capital funds for Indiana-based life sciences start-ups. BioCrossroads’ three Indiana Seed Funds, totaling $24.25 million, have invested in 32 life sciences start-ups since 2006. Those companies have gone on to raise an additional […]